FLORHAM PARK, N.J., June 26, 2017 /PRNewswire/ -- Pazoo, Inc. (OTC: PZOO) is pleased to announce that its wholly owned subsidiary, MA & Associates, LLC, (DBA: MA Analytics) has been approved for a dual-use license by the City of Las Vegas, Nevada.
Currently, Pazoo's laboratory operates as an independent medical marijuana testing laboratory. With the new approval, the laboratory can process recreational marijuana samples. Recreational marijuana will be sold in Nevada starting in July 2017. The testing performed by MA Analytics will protect consumers from contaminants, chemicals and other impurities within the cannabis plant, ensuring that the end consumer is getting the best possible product.
"We are especially pleased with this approval since the City of Las Vegas and State of Nevada have very stringent testing guidelines and by being granted this approval for both medical and recreational cannabis we are now proving the quality of our laboratory," said David Cunic, CEO. "This is a major step forward for the Company and its investors."
About Pazoo, Inc.
Pazoo, Inc. is focused on health, wellness and safety. We provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee Holdings, LLC and MA & Associates, LLC, Pazoo provides industry leading laboratory testing of cannabis. Pazoo's, wholly owned subsidiary, CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the U.S. Non-controlled hemp products are the items utilized by the industry that supports grow facilities, infusion companies and dispensaries.
Safe Harbor Statement
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.
Advertisement
Currently, Pazoo's laboratory operates as an independent medical marijuana testing laboratory. With the new approval, the laboratory can process recreational marijuana samples. Recreational marijuana will be sold in Nevada starting in July 2017. The testing performed by MA Analytics will protect consumers from contaminants, chemicals and other impurities within the cannabis plant, ensuring that the end consumer is getting the best possible product.
Advertisement
"We are especially pleased with this approval since the City of Las Vegas and State of Nevada have very stringent testing guidelines and by being granted this approval for both medical and recreational cannabis we are now proving the quality of our laboratory," said David Cunic, CEO. "This is a major step forward for the Company and its investors."
About Pazoo, Inc.
Pazoo, Inc. is focused on health, wellness and safety. We provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee Holdings, LLC and MA & Associates, LLC, Pazoo provides industry leading laboratory testing of cannabis. Pazoo's, wholly owned subsidiary, CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the U.S. Non-controlled hemp products are the items utilized by the industry that supports grow facilities, infusion companies and dispensaries.
Safe Harbor Statement
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pazoo-inc-subsidiary-receives-city-of-las-vegas-approval-to-test-both-medical-and-recreational-marijuana-in-nevada-300479384.html
SOURCE Pazoo, Inc.
